Concepedia
Statistics
Publications
4
Citations
989
H-Index
Active since
2011
Affiliations
Harvard University(Current)
Massachusetts General Hospital
Agios Pharmaceuticals (United States)
Center for Cancer Research
Hector U. Lopez is an author at Harvard University specializing in medicine, oncology, and molecular oncology.
Publications per year
2011–2014
Frequent Mutation of Isocitrate Dehydrogenase<i>(IDH)1</i>and<i>IDH2</i>in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
Darrell R. Borger, Kenneth K. Tanabe, Kenneth C. Fan et al. · The Oncologist · 2011 · 722 citations · Full text
Medicine, Genetics, Oncology +17
Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response
Amir Fathi, Hossein Sadrzadeh, Darrell R. Borger et al. · Blood · 2012 · 122 citations · Full text
Medicine, Hematology, Oncology +10
Molecular Distinction of Chondrosarcoma From Chondroblastic Osteosarcoma Through IDH1/2 Mutations
Darcy A. Kerr, Hector U. Lopez, Vikram Deshpande et al. · The American Journal of Surgical Pathology · 2013 · 104 citations
Medicine, Molecular Genetics, Oncology +14
Dual HER2 Targeting Impedes Growth of <i>HER2</i> Gene–Amplified Uterine Serous Carcinoma Xenografts
Jolijn W. Groeneweg, Sílvia Hernández, Virginia F. Byron et al. · Clinical Cancer Research · 2014 · 41 citations · Full text
Medicine, Oncology, Pharmacology +15
1–4 of 4